Emulsion mit Cefazolin gegen Psoriasis

EP3124016 Art B1 4. September 2019

Anmelder: Warszawski Uniwersytet Medyczny, INSTYTUT FARMACEUTYCZNY 🇵🇱

Details

Veröffentlichungs-Nr.
EP3124016
Aktenzeichen
EP15460037
Anmeldetag
31. Juli 2015
Veröffentlichung
4. September 2019
Erteilung
4. September 2019
Rechtsraum
EP
IPC
A61K9/107A61K9/113A61K9/06A61K47/02A61K47/06A61K47/08A61K47/10A61K47/18A61K31/546A61P17/06
Offizieller Volltext

Abstract

The present invention relates to the antipsoriatic emulsion composition, especially in the form of a cream, comprising an effective therapeutic dose of cefazolin, the ingredients of the oil phase and the ingredients of the water phase, characterized by that (i) the ingredients of the oil phase include: - liquid paraffin or white petrolatum, - polyoxyethylene stearyl ether (21), and - cetostearyl alcohol; (ii) the ingredients of the oil phase include a buffer solution to maintain the pH value of the initial composition from 5 to 9, preferably in the range 6 - 8, (iii) optionally, comprising an additional amphiphilic nonionic emulsifier, and other soluble/water miscible excipients, wherein water content accounts for 50 to 80% by weight of the composition.

Anmelder

Firmen
Warszawski Uniwersytet Medyczny
INSTYTUT FARMACEUTYCZNY
Land
🇵🇱 Polen

Noch Fragen?

Wir helfen Ihnen gerne weiter. Schreiben Sie uns einfach.

Kontakt aufnehmen